The new prognostic score for unresectable or recurrent gastric cancer treated with nivolumab: A multi‐institutional cohort study

BACKGROUND: Real‐world outcomes of nivolumab treatment for gastric cancer and associated prognostic factors remain unclear; the present study aimed to evaluate both items. METHODS: A total of 278 consecutive patients treated with nivolumab for gastric cancer during 2017‐2019 were enrolled in this mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Sho, Oshima, Yoko, Matsumoto, Yu, Seto, Yasuyuki, Yamashita, Hiroharu, Hayano, Koichi, Kano, Masayuki, Ono, Hidetaka Andrew, Mitsumori, Norio, Fujisaki, Muneharu, Kunisaki, Chikara, Akiyama, Hirotoshi, Endo, Itaru, Ichikawa, Yasushi, Urakami, Hidejiro, Kubo, Hirokazu, Nagaoka, Sakae, Shimada, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560603/
https://www.ncbi.nlm.nih.gov/pubmed/34755011
http://dx.doi.org/10.1002/ags3.12489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560603/
https://www.ncbi.nlm.nih.gov/pubmed/34755011
http://dx.doi.org/10.1002/ags3.12489

Ejemplares similares